Johnson & Johnson (JNJ) News Headlines

▮ More

Date

Headline

1/31/2023 4:34:31 AM Court Rejects J&J Bankruptcy Petition To End Talc Cancer Lawsuits

1/26/2023 2:39:21 AM Evotec Partners With Janssen Biotech To Develop Immune-based Cancer Therapies

1/24/2023 7:41:20 AM Wall Street Might Open Lower

1/24/2023 7:23:33 AM Johnson & Johnson Q4 Profit Down 26%, But Adj. EPS Tops Estimates

1/24/2023 6:39:27 AM Johnson & Johnson Q4 Profit Decreases, but beats estimates

1/24/2023 6:29:07 AM Johnson & Johnson Q4 EPS $1.33; Adj EPS $2.35

1/24/2023 6:00:09 AM Johnson & Johnson Q4 22 Earnings Conference Call At 8:30 AM ET

1/4/2023 9:39:49 PM Johnson & Johnson's Consumer Health Unit Kenvue Files For IPO

12/19/2022 7:30:49 PM Steel Dynamics To Replace Abiomed In S&P 500

12/11/2022 8:19:47 PM Sanofi Says Doesn't Intend To Make Offer For Horizon; But Amgen Reportedly In Advanced Talks

11/30/2022 8:42:14 PM J&J Elects Its CEO Joaquin Duato To Assume Additional Position Of Chairman

11/30/2022 6:48:21 PM Johnson & Johnson Names CEO Joaquin Duato As Chairman Of The Board

11/1/2022 7:37:04 AM Abiomed To Be Bought By Johnson & Johnson In $16.6 Bln Deal; Stock Surges In Pre-market

11/1/2022 6:34:38 AM Johnson & Johnson To Acquire Abiomed For An Upfront Payment Of $380/Shr Cash

10/18/2022 7:10:43 AM Johnson & Johnson Q3 Profit Beats Estimates; Adj. Operational Sales Up 8.2%; Increases Guidance

10/18/2022 6:34:33 AM Johnson & Johnson Q3 Profit Increases, beats estimates

10/18/2022 6:33:23 AM Johnson & Johnson Q3 EPS $1.68; Adjusted EPS $2.55

10/18/2022 6:30:31 AM Johnson & Johnson Q3 EPS $1.68 Vs $1.37 Last Year

10/18/2022 6:00:37 AM Johnson & Johnson Q3 22 Earnings Conference Call AT 8:30 AM ET

9/28/2022 8:06:53 AM Johnson & Johnson Unveils Kenvue Brand Name For Planned Consumer Health Company